Mostrar el registro sencillo del ítem
Revisión documental de la relación de porphyromonas GINGIVALIS y los Anticuerpos anti-péptido citrulinado cíclico en la artritis Reumatoidea
dc.contributor.advisor | Castro Molina, Susan Lorena | |
dc.contributor.author | Pinilla Torres, Laura Lizeth | |
dc.date.accessioned | 2022-10-03T16:36:46Z | |
dc.date.available | 2022-10-03T16:36:46Z | |
dc.date.issued | 2022 | |
dc.identifier.uri | https://repositorio.unicolmayor.edu.co/handle/unicolmayor/5674 | |
dc.description.abstract | Porphyromonas gingivalis es un anaerobio facultativo, Gram negativo con forma cocobacilar, no posee flagelos por lo que es inmóvil, es uno de los microorganismos que con mayor frecuencia se encuentra implicado en la formación de biofilm dental subgingival, por lo que se asocia principalmente con patologías orales como la periodontitis, esta se caracteriza por producir inflamación gingival, produciendo en los casos más graves, degradación de las encías y pérdida ósea. Uno de los factores de virulencia que se encuentran implicados en el desarrollo crónico de la periodontitis es la presencia de la enzima peptidil arginina deaminasa (PPDA), la cual se considera como homóloga a la peptidil arginina deaminasa humana (PAD), implicada en el desarrollo de anticuerpos anti péptido citrulinado cíclico ( Anti - CCP), estos se desarrollan gracias a la catálisis de la arginina en citrulina por medio de esta enzima lo que conlleva a un cambio postransduccional dando como resultado dicha modificación, esto se produce gracias a la activación de la enzima al haber altos niveles de calcio intracelular cuando hay apoptosis o daño celular como en el caso de la artritis reumatoide (AR) por lo que estos anticuerpos se han usado como diagnóstico y pronóstico de esta enfermedad. En la presente revisión se explicarán las posibles formas en las que la enzima PPDA y P. gingivalis son capaces de producir Anti CCP y relacionarse con la AR. | spa |
dc.description.tableofcontents | TABLA DE CONTENIDO RESUMEN.7 INTRODUCCIÓN..8 1. Planteamiento del problema...9 2. Objetivos ....10 2.1 Objetivo General 10 2.3 Objetivos Específicos10 3. Justificación ......11 4. Antecedentes.....11 5. Marco Teórico ..22 5.1 Porhyromonas gingivalis:...22 5.1.1 Factores de Virulencia .23 5.2 Enfermedad periodontal: ...24 5.3 Anticuerpos Anti-Proteínas Citrulinadas (ANTI-CCP). 25 5.4 Artritis Reumatoide .27 5.4.1 Factores de Riesgo.29 6. Diseño metodológico...31 6.1 Tipo de investigación: .....31 6.2 Alcance de la investigación.31 6.3 Población..32 6.4 Muestra ....32 6.5 Variables ..32 6.5.1 Variable dependiente ...32 6.5.2 Variable independiente 32 7. Metodología ......33 7.1 Revisión bibliográfica .....33 7.2 Selección de material bibliográfico.33 8. Resultados..34 9. Discusión ....41 10. Conclusiones ...45 11. Referencias.....46 | spa |
dc.format.extent | 57p. | spa |
dc.format.mimetype | application/pdf | spa |
dc.language.iso | spa | spa |
dc.rights | Derechos Reservados - Universidad Colegio Mayor de Cundinamarca, 2022 | eng |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/4.0/ | spa |
dc.title | Revisión documental de la relación de porphyromonas GINGIVALIS y los Anticuerpos anti-péptido citrulinado cíclico en la artritis Reumatoidea | spa |
dc.type | Trabajo de grado - Pregrado | spa |
dc.description.degreelevel | Pregrado | spa |
dc.description.degreename | Bacteriólogo(a) y Laboratorista Clínico | spa |
dc.publisher.faculty | Facultad de Ciencias de la Salud | spa |
dc.publisher.place | Bogotá | spa |
dc.publisher.program | Bacteriología y Laboratorio Clínico | spa |
dc.relation.references | 1. Ramos D, Moromi H, Martínez E. Porphyromonas gingivalis: patógeno predominante en la periodontitis crónica. Odontol. Sanmarquina [Internet] 2011 [Citado 2021 23 Sep]; 14(1): 34- 38 Disponible en: https://sisbib.unmsm.edu.pe/bvrevistas/odontologia/2011_n1/pdf/a11.pdf | spa |
dc.relation.references | Reyes L. Porphyromonas gingivalis. Trends in Micriobiology. [Internet] 2021 Apr [Cited 2021 23 Sep]; 29(4): 376-377 | spa |
dc.relation.references | Jia L, Han N, Du J, Guo L, Luo Z, Liu Y. Pathogenesis of Important Virulence Factors of Porphyromonas gingivalis via Toll-Like Receptors. Front Biosci. [Internet] 2019 Jul [Cited 2022 20 Feb]; 9:262 Avilable in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657652/ | spa |
dc.relation.references | Firestein GS. Evolving concepts of rheumatoid arthritis. Nature [Internet]. 2003 May 15 [cited 2019 Apr 9];423(6937):356–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12748655 | spa |
dc.relation.references | Klareskog L, Rönnelid J, Lundberg K, Padyukov L, Alfredsson L. Immunity to Citrullinated Proteins in Rheumatoid Arthritis. Annu Rev Immunol [Internet]. 2008 Apr [cited 2019 Apr 10];26(1):651–75. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18173373 | spa |
dc.relation.references | Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. [Internet]. 2010 [cited 2019 Apr 10]; 233(1):34–54. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.0105- 2896.2009.00850.x | spa |
dc.relation.references | Feng L, Zubing L, Yining W, Bin S, Zhongcheng G, Xiangrong C. Porphyromonas gingivalis may play an important role on the pathogenesis of periodontitis-associated rheumatoid arthritis. Medical Hypotheses [Internet] 2009 [Citado 2021 Sep 15]; 72 (6): 732- 735 Available in: https://www.sciencedirect.com/science/article/abs/pii/S0306987709000504?via%3Dihubscien cedir%20ect.com/science/article/abs/pii/S0306987709000504?via%3Dihub | spa |
dc.relation.references | Facultad de odontología sede Bogotá. Guía de Atención en Periodoncia. Universidad Nacional. [Internet] 2013 [Citado 2020 Sep 21]. Disponible en: http://www.odontologia.unal.edu.co/docs/habilitacion/guia_atencion_periodoncia_abril _2013.pdf | spa |
dc.relation.references | Diaz, A. Efecto de Porphyromonas gingivalis en la Activación y Adhesión de Plaquetas Humanas en Co-cultivo con Células Endoteliales de Arteria Coronaria Humana. Universidad del Bosque [Internet] 2018 Nov [Cited 2022 20 Mar]; 333 (1): 1-9 Avilable in: https://repositorio.unbosque.edu.co/bitstream/handle/20.500.12495/2202/Díaz_Real_María_Al ejandra_2018.pdf?sequence=1&isAllowed=y | spa |
dc.relation.references | Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, et al. Periodontitis and Porphyromonas gingivalis in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2014 May;66(5):1090–100. https://pubmed.ncbi.nlm.nih.gov/24782175/ | spa |
dc.relation.references | Shaun M, Antonette G, Rachelle M, Carlos A, Hansel M, Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis. Front Biosci. [Internet] 2008 May [Cited 2022 10 Feb]; 13 (32): 15-38. Avilable in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403687/ | spa |
dc.relation.references | Lunar I, Cascales E. Molecular Strategies Underlying Porphyromonas gingivalis Virulence. JMB. [Internet] 2021 Apr [Cited 2021 23 Sep]; 433(7) | spa |
dc.relation.references | Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol. 2000 Apr;27(4):267–72. https://pubmed.ncbi.nlm.nih.gov/10783841/ | spa |
dc.relation.references | Carvajal Paola. Enfermedades periodontales como un problema de salud pública: el desafío del nivel primario de atención en salud. Rev. Clin. Periodoncia Implantol. Rehabil. Oral [Internet]. 2016 Ago [citado 2022 Mar 15] ; 9( 2 ): 177-183. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0719-01072016000200016&lng=es | spa |
dc.relation.references | Botoreo J, Bedoya E. Determinantes del Diagnóstico Periodontal. Rev. Clin. Periodoncia Implantol. Rehabil. Oral. [Internet] 2010 [Citado 2020 Sep 18]; 3(2); 94- 99. Disponible en: https://scielo.conicyt.cl/pdf/piro/v3n2/art07.pdf | spa |
dc.relation.references | Nagpal R, Yamashiro Y, Izumi Y. The Two-Way Association of Periodontal Infection with Systemic Disorders: An Overview. Mediators Inflamm. 2015;2015:1–9. https://pubmed.ncbi.nlm.nih.gov/26339142/ | spa |
dc.relation.references | Burska AN, Hunt L, Boissinot M, Strollo R, Ryan BJ, Vital E, et al. Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis. Mediators Inflamm. [Internet] 2014 [cited 2019 May 28]; 2014:1–19. Available from: https://pubmed.ncbi.nlm.nih.gov/24782594/ | spa |
dc.relation.references | Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. [Internet] 1999 Jan [cited 2020 Jul 30];162(1):585–94. Available from: https://pubmed.ncbi.nlm.nih.gov/9886436/ | spa |
dc.relation.references | Anderton SM. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol. [Internet] 2004 Dec [cited 2019 29 May];16(6):753– 8. Available from: https://pubmed.ncbi.nlm.nih.gov/15511669/ | spa |
dc.relation.references | Quirke A-M, Fisher BAC, Kinloch AJ, Venables PJ. Citrullination of autoantigens: Upstream of TNFα in the pathogenesis of rheumatoid arthritis. FEBS Lett. [Internet] 2011 Dec [cited 2020 Aug 18];585(23):3681–8. Available from: https://pubmed.ncbi.nlm.nih.gov/21704035/ | spa |
dc.relation.references | Sebbag M, Moinard N, Auger I, Clavel C, Arnaud J, Nogueira L, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol. [Internet] 2006 Aug [cited 2020 Aug 13];36(8):2250–63. Available from: https://pubmed.ncbi.nlm.nih.gov/16838278/ | spa |
dc.relation.references | Gibofsky A. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. [Internet] 2012 Dec [cited 2019 Mar 25];18(13 Suppl):S295-302. Available from: https://pubmed.ncbi.nlm.nih.gov/23327517/ | spa |
dc.relation.references | Nissim A, Winyard PG, Corrigall V, Fatah R, Perrett D, Panayi G, et al. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum. [Internet] 2005 Dec [cited 2019 May 3];52(12):3829–38. Available from: https://pubmed.ncbi.nlm.nih.gov/16329077/ | spa |
dc.relation.references | Bright R, Proudman SM, Rosenstein ED, Bartold PM. Is there a link between carbamylation and citrullination in periodontal disease and rheumatoid arthritis? Med Hypotheses [Internet]. 2015 Jun [cited 2020 Jul 27];84(6):570–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0306987715001115 | spa |
dc.relation.references | Aggarwal R, Liao K, Nair R, Ringold S, Costenbander KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Care Res (Hoboken). [Internet] 2009 Nov [cited 2020 Jul 25];61(11):1472–83. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859449/pdf/nihms 178426.pdf | spa |
dc.relation.references | Sebbag M, Chapuy-Regaud S, Auger I, Petit-Texeira E, Clavel C, Nogueira L, et al. Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis. Jt Bone Spine. [Internet] 2004 Nov [cited 2020 Aug 5];71(6):493–502. Available from: https://www.sciencedirect.com/science/article/pii/S1297319X04001460 | spa |
dc.relation.references | Foulquier C, Sebbag M, Clavel C, Chapuy-Regaud S, Al Badine R, Méchin M C, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD 3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. [Internet] 2007 Nov [cited 2020 Aug 10];56(11):3541–53. Available from: https://pubmed.ncbi.nlm.nih.gov/17968929/ | spa |
dc.relation.references | Correa P, Tobón G, Citera G, Cadena J, Schneeberger E, Camargo J, Et al. Anticuerpos anti-CCP en artritis reumatoidea: relación con características clínicas, citocinas Th1/Th2 y HLA-DRB1. Biomédica [Internet] 2004 [Consultado 9 de septiembre de 2020]; 24:140-152 Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/1260 68. | spa |
dc.relation.references | Casillas F, Bonilla D, Murillo J, Corona E, Contreras M, Saucedo M, Et al. Anticuerpos antipéptido citrulinado cíclico (anti-CCP) en artritis reumatoide. El Residente [Internet] 2015 [Consultado 9 de septiembre de 2020]; 10(1): 12-17. Disponible en: https://www.medigraphic.com/pdfs/residente/rr-2015/rr151c.pdf | spa |
dc.relation.references | Balsa A, Pascual D, Martín J. Anticuerpos anticitrulina en la artritis reumatoide. Med Clin [Internet] 2007 [Consultado 9 de septiembre de 2020]; 128(17):668-673. Disponible en: https://www.elsevier.es/es-revista-medicina-clinica-2-articulo anticuerpos-anticitrulina- artritis-reumatoide-13102061 | spa |
dc.relation.references | Liao F, Li Z, Wang Y, Shi B, Gong Z, Cheng X. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med Hypotheses.[Internet] 2009 Jun [cited 2020 Aug 25];72(6):732–5. Available from: https://www.researchgate.net/publication/24043414_Porphyromonas_gingivalis_may_ play_an_important_role_in_the_pathogenesis_of_periodontitis associated_rheumatoid_arthritis | spa |
dc.relation.references | Del Río P. ACTIVIDAD BIOCIDA DE UN PROPOLIS CHILENO FRENTE A Porphyromonas gingivalis: ESTUDIO in vitro. Universdad de Chile [Internet] 2006 [Citado 2021 23 Sep]; 20-26 Disponible en: http://www.tesis.uchile.cl/tesis/uchile/2006/delrio_p/sources/delrio_p.pdf | spa |
dc.relation.references | Baka Z, György B, Géher P, Buzás EI, Falus A, Nagy G. Citrullination under physiological and pathological conditions. Jt Bone Spine. [Internet] 2012 Oct [cited 2019 Jun 20];79(5):431–6. Available from: https://pubmed.ncbi.nlm.nih.gov/22366145/(7) | spa |
dc.relation.references | Xu W, Zhou W, Wang H, Liang S. Chapter Two - Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Advances in Protein Chemistry and Structural Biology. [Internet] 2020 [Cited 2021 23 Sep]; 120: 45-84 | spa |
dc.relation.references | Bascones A, Figuero E. Las enfermedades periodontales como infecciones bacterianas. Med Oral Patol Oral Cir Bucal. [Internet] 2005 [citado 2020 Sep 20]; 17(3): 92-107. Disponible en: http://scielo.isciii.es/pdf/peri/v17n3/147enfermedades.pdf | spa |
dc.relation.references | Gómez A. Anticuerpos anti-PCC. Rev. Española de Reumatología. [Internet] 2005 [Consultado 9 de septiembre de 2020]. 32(3): 85-87. Disponible en: https://www.elsevier.es/es-revista-revista-espanola-reumatologia-29-articulo anticuerpos-anti- pcc-13073663 | spa |
dc.relation.references | Gutiérrez E, Martínez M,Zapata M, Sánchez S. Artritis Reumatoide: Prevalencia, inmunopatogenia y antígenos relevantes para su diagnóstico. MedPub [Internet] 2012 [Consultado 9 de septiembre de 2020]; 8(1):3. Disponible en: https://www.archivosdemedicina.com/medicina-de-familia/artritis- reumatoideprevalencia-inmunopatogenia-y-antgenos-relevantes-para-su- diagnstio.pdf | spa |
dc.relation.references | Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. [Internet] 2010 [cited 2020 Aug 3];62(9):2569–81. Available from: https://pubmed.ncbi.nlm.nih.gov/20872595/ | spa |
dc.relation.references | Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the - and -Chains of Fibrin. J Immunol. 2001 Mar;166(6):4177–84. | spa |
dc.relation.references | Bang H, Egerer K, Gauliard A, Lüthke K, Rudolph PE, Fredenhagen G, et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum. 2007 Aug;56(8):2503–11. | spa |
dc.relation.references | Kinloch A, Tatzer V, Wait R, Peston D, Lundberg K, Donatien P, et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther. 2005;7(6):R1421-9. | spa |
dc.relation.references | Jones V, Taylor PC, Jacoby RK, Wallington TB. Synovial synthesis of rheumatoid factors and immune complex constituents in early arthritis. Ann Rheum Dis. 1984 Apr;43(2):235–9 | spa |
dc.relation.references | Quirke A-M, Fisher BAC, Kinloch AJ, Venables PJ. Citrullination of autoantigens: Upstream of TNFα in the pathogenesis of rheumatoid arthritis. FEBS Lett. [Internet] 2011 Dec [cited 2020 Aug 18];585(23):3681–8. Available from: https://pubmed.ncbi.nlm.nih.gov/21704035/ | spa |
dc.relation.references | Vander Cruyssen B, Cantaert T, Nogueira L, Clavel C, De Rycke L, Dendoven A, et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther. [Internet] 2006 [cited 2020 Aug 20];8(4):R122. Available form: https://pubmed.ncbi.nlm.nih.gov/16859515/ | spa |
dc.relation.references | Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol. [Internet] 2005 Mar[cited 2020 Aug 23];139(3):542–50. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC18093 | spa |
dc.relation.references | McInnes IB, Schett G. The Pathogenesis of Rheumatoid Arthritis. N Engl J Med [Internet]. 2011 Dec 8 [cited 2019 Mar 15];365(23):2205–19. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMra1004965 | spa |
dc.relation.references | Marcinkiewicz J, Biedroń R, Maresz K, Kwaśny-Krochin B, Bobek M, Kontny E, et al. Oxidative modification of type II collagen differentially affects its arthritogenic and tolerogenic capacity in experimental arthritis. Arch Immunol Ther Exp (Warsz). 52(4):284– 91. https://pubmed.ncbi.nlm.nih.gov/15467493/ | spa |
dc.relation.references | Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GMC, van Veelen P a., et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci. [Internet] 2011 [cited 2019 Jun 8];108(42):17372–7. Available from: https://pubmed.ncbi.nlm.nih.gov/21987802/ | spa |
dc.relation.references | Eggleton P, Nissim A, Ryan BJ, Whiteman M, Winyard PG. Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free Radic Biol Med. [internet] 2013 Apr [cited 2019 Jun 10];57:79–91. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0891584912018060 | spa |
dc.relation.references | Steinbrecher UP, Fisher M, Witztum JL, Curtiss LK. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res. 1984 Oct;25(10):1109–16. | spa |
dc.relation.references | Valesini G, Gerardi MC, Iannuccelli C, Pacucci VA, Pendolino M, Shoenfeld Y. Citrullination and autoimmunity. Autoimmun Rev. [Internet] 2015 Jun [cited 2019 Jun 15];14(6):490–7. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1568997215000282 | spa |
dc.relation.references | Bax M, van Heemst J, Huizinga TWJ, Toes REM. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics. 2011 Aug;63(8):459–66. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132380/ | spa |
dc.relation.references | O’Dell J. Rheumatoid arthritis. In: Goldman L, Schafer AI E, editor. Goldman’s Cecil Medicine. 25th ed. Philadelphia: Elsevier Saunders; 2016. | spa |
dc.relation.references | Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum [Internet]. 1987 Nov [cited 2019 Apr 9];30(11):1205–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2446635 | spa |
dc.relation.references | Nell VPK. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005 Dec;64(12):1731 | spa |
dc.relation.references | Hutchinson D, Shepstone L, Moots R, Lear JT, Lynch MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 2001 Mar;60(3):223–7. Available from: https://pubmed.ncbi.nlm.nih.gov/11171682/ | spa |
dc.relation.references | Källberg H, Ding B, Padyukov L, Bengtsson C, Rönnelid J, Klareskog L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011 Mar;70(3):508–11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033966/pdf/nihms 263734.pdf | spa |
dc.relation.references | Karlson EW, Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 1999 May;42(5):910–7. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/1529- 0131%28199905%2942%3A5%3C910%3A%3AAID-ANR9%3E3.0.CO%3B2-D | spa |
dc.relation.references | Klareskog L, Malmström V, Lundberg K, Padyukov L, Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol. 2011 Apr;23(2):92–8. | spa |
dc.relation.references | Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA–DR (shared epitope)–restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006 Jan;54(1):38–46. | spa |
dc.relation.references | Makrygiannakis D, Hermansson M, Ulfgren A-K, Nicholas AP, Zendman AJW, Eklund A, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008 Oct;67(10):1488–92. | spa |
dc.relation.references | Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum. 2004 Oct;50(10):3085–92. | spa |
dc.relation.references | Linn-Rasker SP. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis. 2006 Mar;65(3):366–71. | spa |
dc.relation.references | Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, et al. Strong combined gene–environment effects in anti–cyclic citrullinated peptide– positive rheumatoid arthritis: A nationwide case–control study in Denmark. Arthritis Rheum. 2007 May;56(5):1446–53. | spa |
dc.relation.references | Lundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. Gene environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: All alleles are important. Arthritis Rheum. 2009 Jun;60(6):1597–603. | spa |
dc.relation.references | Wernick RM, Lipsky PE, Marban-Arcos E, Maliakkal JJ, Edelbaum D, Ziff M. IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum. 1985 Jul;28(7):742–52. | spa |
dc.relation.references | Mysak J, Podzimek S, Sommerova P, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res. [Internet] 2014 Mar [Cited 2022 25 Feb]; 2014 (47) 60-68. Avilable in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984870/# | spa |
dc.relation.references | Bostanci N, Belibasakis G. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiology Letters [Internet] 2012 Aug [Cited 2022 20 Mar]; 333 (1): 1-9 Avilable in: https://academic.oup.com/femsle/article/333/1/1/586464?login=false | spa |
dc.relation.references | Koziel J, Mydel P, Potempa J. The Link Between Periodontal Disease and Rheumatoid Arthritis: An Updated Review. Curr Rheumatol Rep. [Internet] 2014 Jan [Cited 2022 26 Mar]; 16(3): 408 Avilable in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930831/ | spa |
dc.relation.references | Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998 Dec;62(4):1244–63. | spa |
dc.relation.references | Manga P, Wegner N, Venables PJ, Potempa J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? Arthritis Res Ther. 2010;12(3):209. | spa |
dc.relation.references | Koziel J, Mydel P, Potempa J. The link between periodontal disease and rheumatoid arthritis: an updated review. Curr Rheumatol Rep. 2014 Mar;16(3):408. | spa |
dc.relation.references | Socransky SS, Haffajee AD. Effect of Therapy on Periodontal Infections. J Periodontol. 1993 Aug;64(8s):754–9. | spa |
dc.relation.references | Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000. 1999 Jun;20:168–238. | spa |
dc.relation.references | Kesavalu L, Holt SC, Ebersole JL. Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in a murine lesion model. Microb Pathog. 1996 Jan;20(1):1–10. | spa |
dc.relation.references | Birkedal-Hansen H, Taylor RE, Zambon JJ, Barwa PK, Neiders ME. Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodontal Res. 1988 Jul;23(4):258–64. | spa |
dc.relation.references | McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999 Jul;67(7):3248–56. | spa |
dc.relation.references | Wegner N, Wait R, Sroka A, Eick S, Nguyen K-A, Lundberg K, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum [Internet]. 2010 Sep [cited 2019 Jul 29];62(9):2662–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20506214 | spa |
dc.relation.references | Batool H, Afzal N, Shahzad F, Kashif M. Relationship between rheumatoid arthritis and chronic periodontitis. J Med Radiol Pathol Surg. 2016;2(6):11–4. | spa |
dc.relation.references | Rodríguez SB, Stitt BL, Ash DE. Cysteine 351 is an essential nucleophile in catalysis by Porphyromonas gingivalis peptidylarginine deiminase. Arch Biochem Biophys. 2010 Dec;504(2):190–6. | spa |
dc.relation.references | Farquharson D, Butcher JP, Culshaw S. Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunol [Internet]. 2012;5(2):112– 20. Available from: http://dx.doi.org/10.1038/mi.2011.66 | spa |
dc.relation.references | Brinkmann V. Neutrophil Extracellular Traps Kill Bacteria. Science (80- ). 2004 Mar;303(5663):1532–5. | spa |
dc.relation.references | Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol. 2007 Aug;5(8):577–82. | spa |
dc.relation.references | Neeli I, Khan SN, Radic M. Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol. 2008 Feb;180(3):1895–902. | spa |
dc.relation.references | Liubomorova I. State of periodontium in patients affected with rheumatism. Stomatologiia (Mosk). 1964;33 – 37. | spa |
dc.relation.references | Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001 Jun;72(6):779–87. | spa |
dc.relation.references | Arkema E V., Karlson EW, Costenbader KH. A Prospective Study of Periodontal Disease and Risk of Rheumatoid Arthritis. J Rheumatol. 2010 Sep;37(9):1800–4. | spa |
dc.relation.references | Abdelsalam SK, Hashim NT, Elsalamabi EM, Gismalla BG. Periodontal status of rheumatoid arthritis patients in khartoum state. BMC Res Notes. 2011;4(1):460. | spa |
dc.relation.references | 89. Gleissner C, Willershausen B, Kaesser U, Bolten WW. The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur J Med Res. 1998 Aug;3(8):387–92. | spa |
dc.relation.references | 90. Kässer UR, Gleissner C, Dehne F, Michel A, Willershausen-Zönnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum. 1997 Dec;40(12):2248–51. | spa |
dc.relation.references | 91. Cooles FAH, Isaacs JD. Pathophysiology of rheumatoid arthritis. Curr Opin Rheumatol. 2011 May;23(3):233–40. | spa |
dc.rights.accessrights | info:eu-repo/semantics/closedAccess | spa |
dc.rights.creativecommons | Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0) | spa |
dc.subject.lemb | Inflamación | |
dc.subject.lemb | Bacteria | |
dc.subject.lemb | Enzima | |
dc.subject.proposal | Anticuerpos | spa |
dc.subject.proposal | Periodontitis | spa |
dc.subject.proposal | Autoinmunidad | spa |
dc.type.coar | http://purl.org/coar/resource_type/c_7a1f | spa |
dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
dc.type.content | Text | spa |
dc.type.driver | info:eu-repo/semantics/bachelorThesis | spa |
dc.type.redcol | https://purl.org/redcol/resource_type/TP | spa |
dc.type.version | info:eu-repo/semantics/publishedVersion | spa |
dc.rights.coar | http://purl.org/coar/access_right/c_14cb | spa |